Co-targeting WIP1 and PARP induces synthetic lethality in hepatocellular carcinoma.
Miaoqin ChenWeikai WangShiman HuYifan TongYiling LiQi WeiLei YuLiyuan ZhuYiran ZhuLeiming LiuZhenyu JuXian WangHongchuan JinLifeng FengPublished in: Cell communication and signaling : CCS (2022)
WIP1 plays an oncogenic effect in HCC development, and targeting WIP1-dependent DNA damage repair alone or in combination with PARP inhibition might be a reasonable strategy for HCC management. Video abstract.